2015
DOI: 10.1016/j.brs.2014.12.009
|View full text |Cite
|
Sign up to set email alerts
|

Trigeminal Nerve Stimulation (TNS) for Generalized Anxiety Disorder: A Case Study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
10
0
1

Year Published

2015
2015
2022
2022

Publication Types

Select...
5
3

Relationship

1
7

Authors

Journals

citations
Cited by 19 publications
(11 citation statements)
references
References 7 publications
(13 reference statements)
0
10
0
1
Order By: Relevance
“…Peripheral stimulation techniques can be used acutely or chronically to, respectively, abort or prevent pathological symptoms (Fanselow et al 2000;Faingold 2008a, b;DeGiorgio et al 2011). In particular, TNS has been proved effective to terminate symptoms that are impending or actively occurring (Moseley and DeGiorgio 2014;Shiozawa et al 2014;Trevizol et al 2015). This finding is supported by the evidence, reported in animal models of epilepsy (Faingold 2008a, b), that a direct stimulation within the "disease network," particularly at high frequencies, can result in disruptive effects on the network, and that this stimulation may also modulate, simultaneously or sequentially, another network which can compete with the "disease network."…”
Section: Sites Of Action and Possible Mechanismsmentioning
confidence: 99%
See 1 more Smart Citation
“…Peripheral stimulation techniques can be used acutely or chronically to, respectively, abort or prevent pathological symptoms (Fanselow et al 2000;Faingold 2008a, b;DeGiorgio et al 2011). In particular, TNS has been proved effective to terminate symptoms that are impending or actively occurring (Moseley and DeGiorgio 2014;Shiozawa et al 2014;Trevizol et al 2015). This finding is supported by the evidence, reported in animal models of epilepsy (Faingold 2008a, b), that a direct stimulation within the "disease network," particularly at high frequencies, can result in disruptive effects on the network, and that this stimulation may also modulate, simultaneously or sequentially, another network which can compete with the "disease network."…”
Section: Sites Of Action and Possible Mechanismsmentioning
confidence: 99%
“…Trigeminal nuclei are also connected to brain areas such as the nucleus tractus solitarii (NTS) and the LC which are thought to modulate the reticular formation (Foote et al 1983;Aston-Jones et al 1991;Van Bockstaele et al 1999;Fanselow 2012) and disseminate neuromodulatory compound in the central nervous system, since they profoundly affect its excitability at virtually all levels (Moruzzi and Magoun 1949;Foote et al 1983;Vertes 1991;Vertes et al 1999;Ruffoli et al 2011;Fanselow 2012). In addition, the LC and the NTS are believed to play a key role in mediating the clinical benefits observed following TNS in several neurological and neuropsychiatric disorders (Faingold 2008a;Fanselow 2012;Shiozawa et al 2014;Trevizol et al 2015).…”
Section: Sites Of Action and Possible Mechanismsmentioning
confidence: 99%
“…32,33 In this light, an increasing number of studies have shown that TNS is beneficial for seizure control, depression, and migraine, and, very recently, the FDA approved a clinical trial for TNS treatment of Lennox-Gastaut syndrome. 34 In addition to epilepsy and depression, researchers have proposed a clinical application for VNS and TNS for treating variety of disorders, such as migraine, 35 anxiety, 36 cognitive impairment, 37,38 Alzheimer's disease, 39 autism, 40 tinnitus, 41,42 poststroke symptoms, [43][44][45] post-traumatic stress disorder, 46 eating disorders 47 and obesity. 48 Although clinical trials on the topic are accumulating, most of them are preliminary proof-ofconcept pilot studies obtained with limited sample sizes.…”
Section: Clinical Applications Of Vagus-and Trigeminal-nerve Stimulatmentioning
confidence: 99%
“…The authors found significant interaction between the mean percentage change in depressive symptoms in the two groups over time with mean reduction of 6.32 points in the Hamilton Depression Rating Scale (HDRS17); p=0.002 [11]. The same protocol was further used for anxiety disorders with promising results for symptoms ameliorations in post-traumatic stress disorder [12] and generalized anxiety disorder [13]. Regarding tVNS, its use in clinical research is still scant.…”
Section: Editorialmentioning
confidence: 99%